LS2 Intersection Bioinformatics

What is bioinformatics?
Bioinformatics develops and applies computational methods to solve biological questions. Bioinformatics ​is​ ​a transversal ​discipline​ ​in​ ​that​ ​nearly​ ​all areas of Life Science ​have​ ​a bioinformatic component. In each of these domains of application, Bioinformatics accelerate progress through quantitative, integrative, and scalable methods. Conversely, Bioinformatics benefits from the "reality check" and new problems that arise in each domain.

What is SIB?
The SIB Swiss Institute of Bioinformatics is an internationally recognized non-profit organization, dedicated to biological and biomedical data science. Its data scientists are passionate about creating knowledge and solving complex questions in many fields, from biodiversity and evolution to medicine. They provide essential databases and software platforms as well as bioinformatics expertise and services to academic, clinical, and industry groups. SIB federates the Swiss bioinformatics community of some 800 scientists, encouraging collaboration and knowledge sharing. The institute contributes to keeping Switzerland at the forefront of innovation by fostering progress in biological research and enhancing health.

Why this intersection?
The intersection was founded in June 2019, together with SIB Swiss Institute of Bioinformatics, materializing the fact that bioinformatics and life sciences feed from each other. Through activities determined by its board, this intersection aims to 1) create additional bridges between the two disciplines, 2) foster collaborations between SIB Members and LS2 Members, and 3) accelerate the development of methods and tools supporting the latest experimental developments.

The Bioinformatics Intersection welcomes any LS2 member willing to discover more about bioinformatics and participate in common activities.

Intersection Board

President

Katja Bärenfaller
SIB Group Leader, Head Molecular Allergology Group, Swiss Institute of Allergy and Asthma Research, SIAF

Vice-president

Carlos-Andrés Peña-Reyes
SIB Group Leader, Computational Intelligence for Computational Biology, HEIG-VD

Board Member

Paulina Pacak
Deputy Head of Computational Chemistry, RDP Pharma AG

Board Member

Zsolt Balázs
Senior Researcher, University of Zurich

Board Member

Cheng Li
Postdoctoral Researcher, University of Zurich

News and Events:

ECCB 2026

The 25th European Conference on Computational Biology (ECCB 2026) will bring more than 1,000 experts to Geneva to discuss advances in AI, biodiversity, health, FAIR data, and digital twins. Organized by SIB, the conference is part of #GenevaLovesData, a broader public programme highlighting the societal impact of life-science data and bioinformatics, and reinforcing Geneva’s role as a hub for trusted data and international collaboration.

Register by June 30 to benefit from early bird fees. Registration closes on August 14. 

CAS in Personalized Molecular Oncology

Registration is open for the CAS in Personalized Molecular Oncology (PMO), starting in November 2026. This interdisciplinary programme (10 ECTS + CME, in English) covers tumor biology, molecular pathology, clinical bioinformatics, and oncology, addressing key challenges in genomic medicine. It is designed for professionals in precision medicine and jointly organized by SIB, the University of Basel, Basel University Hospital, and CHUV.

The whole Program lasts for 10-12 months (incl.mini-thesis). Modules take place alternately in Lausanne and Basel , and consist of 4 days of presential teaching, over two Friday-Saturday sessions.

Participants interested in joining single modules of the CAS are welcome to apply by sending an email with their CV to cas-pmo@unibas.ch (latest 3 weeks before the start of the module of interest).

Applications for the CAS session 2026-2027 are now open and will close on September 30, 2026.

Discover the new SIB Profile 2026

Explore SIB’s latest activity report showcasing contributions to life-science research, innovation, and data science in Switzerland and beyond. The report highlights advances in areas such as environmental sustainability and the next generation of cancer care, alongside SIB’s role in supporting scientific excellence and national competitiveness through bioinformatics expertise.

Have a look at the recently released SIB YouTube video on "The benefits of bioinformatics to science and society”!

screenshot-2026-01-27-153007.png

Resources

Discover databases and software tools provided by SIB Groups to the global life science community. Find out more here.

Benefit from the SIB courses to hone your bioinformatics skills. Discover the latest advances in computational biology to explore biological data, from single-cell molecular insights to vaccine development and real-time pathogen tracking. 

Upcoming training courses.

e-learning.

Expasy.org - the Swiss Bioinformatics Resources' Portal

Expasy (https://www.expasy.org/), the bioinformatics resource portal of the SIB Swiss Institute of Bioinformatics, connects the 160+ bioinformatics databases and software developed by SIB Groups and supporting research in proteomics, genomics, structural biology, evolution, systems biology, text mining.